STOCK TITAN

Cronos Group Inc. to Reconvene Virtual 2024 Annual Meeting of Shareholders

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Cronos Group (NASDAQ: CRON, TSX: CRON) announced the reconvening of its 2024 Annual Meeting of Shareholders on July 19, 2024, at 11:00 a.m. ET. The meeting will be held virtually via a live audio webcast, allowing equal participation for all registered shareholders and proxyholders regardless of location. Attendees will have the opportunity to ask questions and vote. The record date for the Annual Meeting remains April 25, 2024. Detailed instructions and the proxy statement are available on Cronos’ investor relations website.

Positive
  • Virtual meeting format ensures equal access for all shareholders and proxyholders, enhancing participation.
  • Shareholders and proxyholders can ask questions and vote online, promoting engagement and transparency.
Negative
  • Reconvening of the Annual Meeting suggests potential issues or delays, impacting investor confidence.

TORONTO, July 05, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announced today that it will reconvene its 2024 Annual Meeting of Shareholders on Friday, July 19, 2024, at 11:00 a.m. ET.

Cronos will be conducting the reconvened meeting in a virtual-only format via live audio webcast. Registered shareholders and duly appointed proxyholders will have an equal opportunity to participate in the reconvened 2024 Annual Meeting online regardless of their geographic location, including a chance to ask questions and vote.

The record date for the Annual Meeting continues to be April 25, 2024.

The Company’s proxy statement and proxy supplement describing the formal business to be conducted at the meeting and containing detailed instructions about how to participate in the meeting are available on the Investors section of the Company’s website at https://ir.thecronosgroup.com/financial-information/annual-meeting.

Access Information
Date: Friday, July 19, 2024
Time: 11:00 a.m. ET
Live Audio Webcast Online at: http://www.virtualshareholdermeeting.com/CRON2024

Replay

A replay of the reconvened Annual Meeting will be available in the investor relations section of the Company’s website (https://ir.thecronosgroup.com/events-presentations) starting about 24 hours after the meeting is finished.

About Cronos

Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos’ diverse international brand portfolio includes Spinach®, PEACE NATURALS® and Lord Jones®. For more information about Cronos and its brands, please visit: thecronosgroup.com.

Forward-looking Statements

This press release may contain information that may constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws and court decisions (collectively, “Forward-looking Statements”). All information contained herein that is not clearly historical in nature may constitute Forward-looking Statements. In some cases, Forward-looking Statements can be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “plan”, “anticipate”, “intend”, “potential”, “estimate”, “believe” or the negative of these terms, or other similar expressions intended to identify Forward-looking Statements. Some of the Forward-looking Statements contained in this press release include statements about Cronos’ intention to build an international iconic brand portfolio and develop disruptive intellectual property. Forward-looking Statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks. Financial results, performance or achievements expressed or implied by those Forward-looking Statements and the Forward-looking Statements are not guarantees of future performance. A discussion of some of the material risks applicable to the Company can be found in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 and Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, each of which has been filed on SEDAR+ and EDGAR and can be accessed at www.sedarplus.ca and www.sec.gov/edgar, respectively. Any Forward-looking Statement included in this press release is made as of the date of this press release and, except as required by law, Cronos disclaims any obligation to update or revise any Forward-looking Statement. Readers are cautioned not to put undue reliance on any Forward-looking Statement.

Cronos Group Contact
Shayne Laidlaw
Investor Relations
Tel: (416) 504-0004
investor.relations@thecronosgroup.com


FAQ

When is Cronos Group's reconvened 2024 Annual Meeting?

Cronos Group's reconvened 2024 Annual Meeting will be held on July 19, 2024, at 11:00 a.m. ET.

How can shareholders participate in the Cronos 2024 Annual Meeting?

Shareholders can participate in the 2024 Annual Meeting online via a live audio webcast by visiting http://www.virtualshareholdermeeting.com/CRON2024.

Where can I find the proxy statement and instructions for the Cronos 2024 Annual Meeting?

The proxy statement and detailed instructions for the Cronos 2024 Annual Meeting are available on the Investors section of the Cronos Group website.

What is the record date for the Cronos Group 2024 Annual Meeting?

The record date for the Cronos Group 2024 Annual Meeting is April 25, 2024.

Will there be a replay available for Cronos Group's 2024 Annual Meeting?

Yes, a replay of the Cronos Group 2024 Annual Meeting will be available in the investor relations section of the Company’s website starting about 24 hours after the meeting.

Cronos Group Inc. Common Share

NASDAQ:CRON

CRON Rankings

CRON Latest News

CRON Stock Data

716.80M
200.23M
46.4%
15.62%
1.02%
Drug Manufacturers - Specialty & Generic
Medicinal Chemicals & Botanical Products
Link
United States of America
STAYNER